Search Results - miguel+aller+pellitero

2 Results

Sort By:

Anti-Human IgG–Invertase Fusion Protein for Quantitative Immunosensing Using Glucometers

Unmet Need / Invention Novelty To mitigate the spread of infectious diseases, rapid and widely available testing methods are needed to screen immunity at the population scale. Current antibody quantification assays often require lab-based instrumentation and methodology that can only be used/followed by skilled personnel. Unfortunately, at-home tests...

Published: 5/10/2024 | Inventor(s): Jamie Spangler, Miguel Aller Pellitero, Boris Juelg, Netzahualcoyotl Arroyo, Elissa Leonard

Keywords(s):

Category(s): Clinical and Disease Specializations > Infectious Diseases, Technology Classifications > Diagnostics, Technology Classifications > Diagnostics > In Vivo Diagnostics

Platform for Population-Scale Screening of COVID-19 Antibodies

Unmet NeedCOVID-19 is a disease caused by the novel coronavirus SARS-CoV-2. As of September 2020, there are over 33 million cases of COVID-19 globally, resulting in 1 million deaths from the virus. Due to diverse individual responses to the virus and limited testing, it has been particularly hard to identify individuals that present no or mild symptoms...

Published: 5/10/2024 | Inventor(s): Netzahualcoyotl Arroyo, Jamie Spangler, Taekjip Ha, Elissa Leonard, Miguel Aller Pellitero, Soojung Hur, Harrison Khoo

Keywords(s):

Category(s): Clinical and Disease Specializations > Infectious Diseases, Technology Classifications > Medical Devices, Technology Classifications > Diagnostics